Clinical Trial

Diagnostic Accuracy of Clinical Tests and Diagnostic Criteria for Piriformis Syndrome

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Piriformis syndrome is a clinical condition characterized by buttock pain and/or sciatic-like symptoms, and its diagnosis remains challenging because there is no universally accepted diagnostic standard. This study aims to evaluate the diagnostic accuracy of commonly used diagnostic criteria and clinical tests for piriformis syndrome. Participants with suspected piriformis syndrome will undergo standardized physical examination and assessment of predefined diagnostic criteria. Ultrasound-guided injection of 5 mL of 2% lidocaine into the piriformis muscle will be used as the reference diagnostic procedure. A reduction of 50% or more in pain after injection will be considered confirmation of piriformis syndrome. The diagnostic performance of clinical tests and diagnostic criteria will be analyzed accordingly.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-13.
Trial Details
NCT Number NCT07473349
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Piriformis Syndrome, Gluteal Pain
Enrollment 75 participants
Start Date 2026-03-15
Primary Completion 2026-09-15 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-17